Jeffrey Rothstein

29PUBLICATIONS

196CO-AUTHORS

Neurology and neuromuscular diseasesAutonomic nervous systemPredictive and prognostic markersRheumatology and arthritisCentral nervous system

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (29)

Sort by Publication Date:

|Jun 22, 2026

Mutant SOD1 expressed by oligodendrocytes aggregates in myelinic nanochannels and accelerates disease progression in familial ALS mice.

|Feb 06, 2026

Is SORL1 a common genetic target across neurodegenerative diseases?: A multi-ancestry biobank scale assessment.

Marzieh Khani, Sheila N Yeboah, Catalina Cerquera-Cleves

|Jan 16, 2026

Identification of molecular and clinical ALS subgroups based on TDP-43 loss of function molecular markers from population-based patient-derived iPS motor neurons.

Trinity Cheng, Shaili Tripathi, Yike Guo

|Dec 23, 2025

Phase 3b Extension Study MT-1186-A04 to Evaluate the Continued Efficacy and Safety of Edaravone Oral Suspension for Up to an Additional 48 Weeks in Patients With Amyotrophic Lateral Sclerosis.

Angela Genge, Jeffrey Rothstein, Shari De Silva

|Dec 22, 2025

Mapping the circulating proteome across neurodegeneration: A harmonized, consortium-scale framework for uncovering molecular pathophysiology.

Caitlin A Finney, Lijun An, Laura M Winchester

|Aug 02, 2025

Sporadic ALS induced pluripotent stem cell derived neurons reveal hallmarks of TDP-43 loss of function.

Jeffrey D Rothstein, Olivia Keeley, Caroline Warlick

Pageof 5

Frequent Collaborators

Alyssa N Coyne

C Patrick Lusk

Dennis W Dickson

Jennifer E Van Eyk

Yongjie Zhang

Jonathan D Glass

Brett M Morrison

Leonard Petrucelli

Tania F Gendron

Dwight E Bergles

Frequent Collaborators

Alyssa N Coyne

C Patrick Lusk

Dennis W Dickson

Jennifer E Van Eyk